Skip to content
Logo of EDN, a company with a modern, clean design.
  • Home
  • About MedNet
  • Live Programs
  • Webcasts
  • Contact
  • Log in/Registration
Search
Close
  • Home
  • About MedNet
  • Live Programs
  • Webcasts
  • Contact
  • Log in/Registration
×
  • Home
  • About MedNet
  • Live Programs
  • Webcasts
  • Contact
  • Log in/Registration
0

0
Sub-Total: $0.00

No products in the cart.

100% Secure Checkout!
Home / Specialty / Neurology / 3rd Annual Symposium on Individualized Novel Disease-Modifying Treatment Options for Multiple Sclerosis

3rd Annual Symposium on Individualized Novel Disease-Modifying Treatment Options for Multiple Sclerosis

Complimentary

Categories: Activity Type, ANCC, CME, Credit Type, Neurology, Nurse, Nurse Practitioner, Online Activity, Physician, Physician Assistant, Profession
People wearing masks wait in a socially distanced medical facility with a healthcare worker in PPE.

Related products

  • Close-up of an elderly person's eye with a digital overlay and a fish inset.

    New Paradigms in the Treatment and Management of Age-related Macular Degeneration (AMD)

    Read more
  • Close-up of a human eye with a retinal scan overlay and an inset image of the retina.

    New Paradigms for Treatment and Management of Retinal Vein Occlusion (RVO)

    Read more
  • Close-up of a human eye with a futuristic, glowing digital interface.

    Ocular Surface Disease: Pathophysiology, Evaluation, Management with Topical Agents, and Neuromodulation

    Read more
  • Close-up of a hand with red, irritated skin showing signs of eczema or dermatitis.

    New Paradigms in the Biological Therapies for Atopic Dermatitis

    Read more
Logo of EDN, a company with a modern, clean design.
  • 860 Hebron Pkwy., Suite 1104
    Lewisville, TX 75057

Site Links

  • Home
  • About MedNet
  • Live Programs
  • Webcasts
  • Contact
  • Log in/Registration

Quick Links

  • Cart
  • Checkout
  • Terms of Service

Categories

© 2026, MedNet. All Rights Reserved.

GoDaddy Web Design
Scroll To Top